作者：

陈 斌, 赵红利

陈 斌，赵红利

Author(s):

Chen Bin 1 Zhao Hongli 2

Chen Bin 1 Zhao Hongli 2

单位:

1.榆林市榆阳区中医医院､榆阳区青山路社区卫生服务中心,陕西榆林719000; 2.西安市新城区东郊第一职工医院,陕西西安710038

Unit:

1. Yulin District TCM Hospital of Yulin, Community Health Service Center in Qingshan Road of Yuyang District, Yulin China, 719000; 2. First Staff Hospital of Xincheng District in Xi’ an, Xi’ an China, 710038

关键词:

冠心病; 六君子汤; 介入治疗; 支架; 气虚血瘀

冠心病；六君子汤；介入治疗；支架；气虚血瘀

分类号:

R256.22

DOI:

10.13424/j.cnki.mtcm.2019.03.014

文献标识码:

A

摘要:

目的分析探讨六君子汤合丹参饮对气虚血瘀证冠心病患者经皮冠状动脉介入治疗术后支架内再狭窄的影响｡方法选取我院于2015年1月~2017年1月期间收治的95例气虚血瘀证冠心病患者,按照随机数字表法将所有患者随机分为对照组和治疗组两组,所有患者均采取经皮冠状动脉介入术进行治疗,其中对照组患者均给予硝酸酯类､他汀类､阿司匹林､氯吡格雷等药物进行治疗,而治疗组患者则在此基础上联合使用六君子汤合丹参饮进行治疗,所有患者均持续治疗3个月｡记录两组患者治疗前后的气虚积分和证候积分､支架再狭窄率以及血瘀积分等指标,比较两组

参考文献
/References:

[1]赵宗磊,杜松,罗萍,等.益气活血法治疗不稳定型心绞痛PCI术后支架内再狭窄临床研究[J].中医学报,2017,32(11):2200-2203.
[2] Waldmann V, Laredo M, Nigam A, et al. Cyclical sinusbradycardia and atrioventricular block induced by ticagrelor[ J] . HeartRhythm Case Rep, 2018, 4( 11) : 527-529.
[3]仇卫锋,刘佳,向宗兴,等.加味丹参饮对冠心病血管内皮细胞损伤后细胞形态学的影响[J].陕西中医,2016,37(8):1042-1043.
[4] Liu Q, Fan J, Bai J, et al. IL - 34 promotes foam cellformation by enhancing CD36 expression through p38MAPK pathway[ J] . Sci Rep, 2018,8( 1) :17347.
[5]陈浩,邓悦.冠心病心绞痛代谢组学的证候客观化研究[J].世界科学技术-中医药现代化,2017,19(5):797-803.
[6] Fishman SL, Sonmez H, Basman C, et al. The role of advanced glycation end - products in the development of coronary artery disease in patients with and without diabetesmellitus: a review[ J] . Mol Med, 2018,24( 1) :59.
[7]杨威,宁微,李滕等.养心氏片治疗气虚血瘀型冠心病PCI术后心绞痛的临床观察[J].世界中医药,2018,13(3):614-615. [ 8] Sani CM, EPL P, Hrabia JB, et al. Association betweenlow - grade chronic inflammation and depressed left atrialcompliance in heart failure with preserved ejection fraction: A retrospective analysis [ J] . Folia Med Cracov,2018,58( 2) :45 -55.
[9]Sunyecz IL, McCallinhart PE, Patel KU, et al. DefiningCoronary Flow Patterns: Comprehensive Automation ofTransthoracic Doppler Coronary Blood Flow[ J] . Sci Rep,2018,8( 1) :17268.
[10]胡国恒,王瑾茜,刘侃,等.益气活血组方治疗冠心病心肌缺血的临床观察[J].中国中医急症,2016,25(10):1940-1942.
[11]唐胜,沈建锋,谢玉华,等.自拟益气活血方治疗冠心病慢性心力衰竭临床效果及对炎症因子水平的影响[J].河北中医药学报,2018,33(1):11-14.
[12] Mehta SR. Nonculprit Lesion Intervention: 1 Step Closerto the COMPLETE Answer[ J] . JACC Cardiovasc Interv,2018,11( 22) :2274 -2275.
[13]汪强,谷惠敏,朱建中,等.补阳还五汤治疗气虚血瘀型冠心病心绞痛的临床回顾性研究[J].南京中医药大学学报,2017,33(6):579-582.
[14] Hu PT, Jones WS, Glorioso TJ, et al. Predictors andOutcomes of Staged Versus One - Time Multivessel Revascularization in Multivessel Coronary Artery Disease: Insights From the VA CART Program[ J] . JACC Cardiovasc Interv, 2018,11( 22) :2265 -2273.
[15]郑丽莉.芎归六君子汤对实验性大鼠冠心病的治疗作用[J].中国比较医学杂志,2018,28(1):23-27,55.
[16] Garcia S, Bhatt DL, Gallagher M, et al. Strategies toReduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention: A Subgroup Analysis of the PRESERVE Trial [ J] . JACCCardiovasc Interv, 2018,11( 22) :2254 -2261.